SCHEMBL9422646

SCHEMBL9422646

[O-][n+]1cncc2nccnc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28665764 0.71
SCHEMBL457081 0.69 KDM4E (0.35)
SCHEMBL9901185 0.65 KDM4E (0.38)
SCHEMBL3279288 0.65 EGFR (0.34)
SCHEMBL7011802 0.64
SCHEMBL5894455 0.60 ALDH1A1 (0.41)
SCHEMBL14989378 0.58
SCHEMBL88851 0.56 KDM4A (0.39)
SCHEMBL29428806 0.56 KDM4A (0.39)
SCHEMBL30237822 0.56 KDM4A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6001790-A None JP disclosed
JP-H061790-A SUBSTITUTED PYRAZINO(2,3-D)PYRIMIDINONES AS ANGIOTENSIN II ANTAGONISTS MERCK & CO INC 1994-01-11 JP disclosed
EP-0537937-A2 Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists MERCK & CO. INC. (US) 1993-04-21 EP disclosed
EP-0537937-A2 Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists MERCK & CO. INC. (US) 1993-04-21 EP disclosed